Ebrahimi, E., & Shirkoohi, R. (2018). What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?. Archives of Breast Cancer, 148-149. https://doi.org/10.32768/abc.201854148-149